Shree Ganesh Remedies Limited (BOM:540737)
India · Delayed Price · Currency is INR 649.35
+1.10 (0.17%)
At close: May 29, 2026
Shree Ganesh Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 177.6 | 230.68 | 281.08 | 170.2 | 133.99 |
Depreciation & Amortization | 104.73 | 95.67 | 59.22 | 35.98 | 33.99 |
Loss (Gain) From Sale of Assets | 0.07 | -0.01 | 0.05 | -0.19 | - |
Asset Writedown & Restructuring Costs | - | - | 1.88 | 1.88 | - |
Loss (Gain) From Sale of Investments | -8.63 | -7.7 | -2.45 | - | -2.64 |
Other Operating Activities | 34.35 | 5.34 | 19.39 | -0.82 | -50.24 |
Change in Accounts Receivable | -94.49 | -14.79 | 80.38 | -95.66 | -50.53 |
Change in Inventory | -19.87 | 29.7 | -68.12 | -45.35 | -9.28 |
Change in Accounts Payable | 34.71 | -22.31 | -72.5 | 50.6 | 26.65 |
Change in Other Net Operating Assets | 8.95 | -9.95 | 5.57 | 53.46 | 52.24 |
Operating Cash Flow | 237.42 | 306.64 | 304.49 | 170.11 | 134.17 |
Operating Cash Flow Growth | -22.57% | 0.71% | 78.99% | 26.79% | 305.16% |
Capital Expenditures | -165.98 | -231.95 | -311.38 | -515.83 | -153.28 |
Sale of Property, Plant & Equipment | 0.15 | 0.19 | 0.03 | 0.3 | - |
Investment in Securities | 66.32 | -125.04 | -19.38 | - | 34.11 |
Other Investing Activities | 0.61 | 0.21 | 0.64 | -20.22 | 0.04 |
Investing Cash Flow | -98.9 | -356.58 | -330.09 | -535.75 | -119.13 |
Short-Term Debt Issued | - | - | - | - | 6.01 |
Long-Term Debt Issued | 0.04 | 16.55 | 45.52 | 309.32 | - |
Total Debt Issued | 0.04 | 16.55 | 45.52 | 309.32 | 6.01 |
Short-Term Debt Repaid | - | - | - | - | -0.37 |
Long-Term Debt Repaid | -81.04 | -6.92 | -8.57 | - | -0.42 |
Total Debt Repaid | -81.04 | -6.92 | -8.57 | - | -0.79 |
Net Debt Issued (Repaid) | -81.01 | 9.62 | 36.95 | 309.32 | 5.22 |
Issuance of Common Stock | - | - | 73.66 | 109.98 | - |
Common Dividends Paid | - | - | -6.26 | -6 | -16.09 |
Other Financing Activities | -35.95 | -20.51 | -5.95 | - | - |
Financing Cash Flow | -116.95 | -10.88 | 98.41 | 413.31 | -10.87 |
Foreign Exchange Rate Adjustments | 12.92 | 1.75 | -0.83 | - | - |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - |
Net Cash Flow | 34.49 | -59.07 | 71.97 | 47.67 | 4.17 |
Free Cash Flow | 71.44 | 74.69 | -6.9 | -345.72 | -19.11 |
Free Cash Flow Growth | -4.35% | - | - | - | - |
Free Cash Flow Margin | 6.54% | 6.88% | -0.55% | -38.32% | -2.68% |
Free Cash Flow Per Share | 5.56 | 5.82 | -0.55 | -28.16 | -1.56 |
Cash Interest Paid | 35.95 | 20.51 | 5.95 | - | - |
Cash Income Tax Paid | 48.25 | 100.53 | 81.37 | 58.99 | 40.09 |
Levered Free Cash Flow | 12.56 | 6.65 | -91 | -412.07 | -71.29 |
Unlevered Free Cash Flow | 34.82 | 19.22 | -87.59 | -411.79 | -70.64 |
Change in Working Capital | -70.7 | -17.35 | -54.68 | -36.94 | 19.08 |